| [1] | Swamynathan M. M., Kuang S., Watrud K. E., et al. (2024). Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function. Science 386:eadk9167. DOI:10.1126/science.adk9167 |
| [2] | Hanahan D. and Weinberg R. A. (2011). Hallmarks of cancer: the next generation. Cell 144:646−674. DOI:10.1016/j.cell.2011.02.013 |
| [3] | Zhao W., Li S., Chen R., et al. (2023). RXR signaling targeted cancer therapy. The Innovation Life 1:100014. DOI:10.59717/j.xinn-life.2023.100014 |
| [4] | Klein E. A., Thompson I. M., Jr., Tangen C. M., et al. (2011). Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama 306:1549−1556. DOI:10.1001/jama.2011.1437 |
| [5] | Yuan J. and Ofengeim D. (2024). A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25:379−395. DOI:10.1038/s41580-023-00689-6 |
| Qiao M., Fang Y. and Huang J. (2025). Triaptosis: Pro-oxidant-induced programmed cell death. The Innovation Life 3:100126. https://doi.org/10.59717/j.xinn-life.2025.100126 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Pro-oxidant-induced PI(3)P depletion and endosomal dysfunction drive Triaptosis